Evaluating Nanopore sequencing as a rescue strategy for HIV-1 drug-resistance genotyping of low-yield PCR products. // Journal of Clinical Virology. – URL: https://www.sciencedirect.com/science/article/pii/S1386653226001150?dgcid=rss_sd_all
Evaluating Nanopore sequencing as a rescue strategy for HIV-1 drug-resistance genotyping of low-yield PCR products. Journal of Clinical Virology. https://www.sciencedirect.com/science/article/pii/S1386653226001150?dgcid=rss_sd_all
“Evaluating Nanopore sequencing as a rescue strategy for HIV-1 drug-resistance genotyping of low-yield PCR products.” Journal of Clinical Virology.
@article{article52762,
title = {Evaluating Nanopore sequencing as a rescue strategy for HIV-1 drug-resistance genotyping of low-yield PCR products},
journal = {Journal of Clinical Virology},
url = {https://www.sciencedirect.com/science/article/pii/S1386653226001150?dgcid=rss_sd_all}
}
ABSTRACT Background Aspergillus fumigatus can cause life‐threatening infections, primarily treated with azole antifungals. Azole‐resistant A. fumigatus (ARAF) is a major clinical concern. Environmental resistance development is an...
ABSTRACT Background The lipid‐dependent yeast genus Malassezia is composed of skin commensals that can become pathogenic. This genus can cause bloodstream infection in low‐weight preterm neonates and immunocompromised adults. However,...